Role of cenicriviroc in the management of nonalcoholic fatty liver disease

doi:10.3748/wjg.v24.i48.5415

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6514)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

564

WORD

248

HTML

3823

Figures (1-1)

161

Sum=4796

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

789

Download

929

Sum=1718

Dec 28, 2018 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Dec 28, 2018; 24(48): 5415-5417
Published online Dec 28, 2018. doi: 10.3748/wjg.v24.i48.5415

Open in New Tab Full Size Figure Download Figure

Figure 1 Molecular pathway through which cenicriviroc acts. TGFβ: Transforming growth factor β; PDGF: Platelet-derived growth factor; MMPs: Matrix metalloproteinases; CCL-2/CCR2: Chemokine (C-C motif) ligand 2/ C-C chemokine receptor 2.

Citation: Neokosmidis G, Tziomalos K. Role of cenicriviroc in the management of nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(48): 5415-5417
URL: https://www.wjgnet.com/1007-9327/full/v24/i48/5415.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i48.5415